Navigation Links
Funding Tomorrow's Biomedical Research: California Healthcare Institute Hosts Pipeline for Life, July 15
Date:7/11/2013

LA JOLLA, Calif. (PRWEB) July 11, 2013

WHAT: CHI-California Healthcare Institute is hosting Pipeline for Life: Revitalizing Our Biomedical Research Ecosystem for a Healthier Tomorrow in La Jolla, California. Sequestration is putting enormous pressure on government funding for research programs that form the scientific base for innovative medical advances for patients.

WHO: Top academic leaders and industry executives from: Allergan, Bristol-Myers Squibb, Cedars-Sinai, Bay City Capital, Genzyme, The Scripps Research Institute, J. Gladstone Institutes, Gilead Sciences, Bay City Capital, City of Hope, Thermo Fisher Scientific, Health and policy experts from CHI, University of California, Irvine, University of California, San Diego and more.

WHY: At Pipeline for Life, California Healthcare Institute (CHI) will convene an extraordinary group of biomedical industry leaders and influential policymakers for focused discussions on success in basic research, public policy, modernizing innovation and strategy while reshaping the market for medical innovation and research inspiration for success in new therapies and medical technologies. This event brings together representatives from CHI’s member organizations with policymakers to discuss critical issues and opportunities facing the biomedical community. The goal of the Pipeline for Life is to produce a clearer understanding of the biomedical community’s work and needs, and how the industry can sustain California’s leadership in biomedical research and innovation.

WHO SHOULD ATTEND: Leaders from California’s biomedical industry, academic research community, entrepreneurs, healthcare providers, investors, members of the media, policy experts and patient advocates.

WHEN: Monday, July 15, 2013
Registration: 11:30 a.m. – noon
Welcoming Lunch: noon - 1:10 p.m.
Panel discussions and keynotes: 1:15 – 5:00 p.m.
Reception: 5–6 p.m.

WHERE: The Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, California

For more information, visit chi.org/events

Media Inquiries & Event Registration:
Erica Hiar
202-974-6322
Hiar(at)chi(dot)org

About CHI
CHI represents more than 275 leading biotechnology, medical device, diagnostics, and pharmaceutical companies, and public and private academic biomedical research organizations. CHI’s mission is to advance responsible public policies that foster medical innovation and promote scientific discovery. CHI’s website is http://www.chi.org. Follow us on Twitter @calhealthcare, Facebook, LinkedIn and YouTube.

Read the full story at http://www.prweb.com/releases/2013/7/prweb10918157.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Crowdfunding Expert Kendall Almerico Discusses Crowdfunding for Science
2. SPIE Leaders Commend OMB Support for Travel to Scientific Conferences, Say Funding is Also Needed
3. Pittsburgh Life Sciences Greenhouse Makes Significant Reductions Due to Uncertain Funding
4. NSBRI Industry Forum Launches SMARTCAP-Accel, a Grant Funding Opportunity to Catalyze Development of Products for Spaceflight
5. Patheon to Host Complimentary Seminar on “Formulation, Funding and First-in-Man: A Stepwise Guide to Clinical Success”
6. NIH Saves Lives: Fred Hutchinson Cancer Research Center Calls On Congress To Restore Full NIH Funding
7. Real Time Genomics Secures a $5 Million Round of Funding to Expand Commercial Operations
8. SPIE Encouraged By Increased Science Funding in Obama Budget, Urges Applied Research Emphasis
9. Suspect Detection Systems Receives Funding From Israel-Publicly Traded Biomedix Ltd.
10. BioHealth Innovation, Inc. Launches Program to Help Life Science Companies Navigate Federal Funding Application Process
11. VG Life Sciences, Inc. Secures Two-Year Funding Commitment and Administrative Support from MedBridge, LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... , March 23, 2017 According to ... products and derivatives market is fragmented due to the presence of a ... as Proliant, Thermo Fisher , and Sigma-Aldrich, compete with each ... three companies, collectively, held more than 76% of this market in ... As of ...
(Date:3/22/2017)... , March 22, 2017 Regeneron Pharmaceuticals, Inc. (NASDAQ: ... Genetics Center (RGC), U.K. Biobank and GSK to generate genetic ... Biobank resource. The initiative will enable researchers to gain valuable ... for a wide range of serious and life threatening diseases. ... Genetic ...
(Date:3/22/2017)... Good Start Genetics, a leading family genomics ... million covered lives mark through its most recent payor ... . With newly signed contracts nationally and others ... payor acceptance based on the quality of its science, ... its industry-leading customer care and support and its published ...
(Date:3/22/2017)... , March 22, 2017 MarketNewsUpdates.com News ... ... conditions are being pressured as of late due to the ... pain management has a dramatic impact on patient,s quality of ... development activities for identifying new forms of opioid formulations that ...
Breaking Biology Technology:
(Date:2/10/2017)... Feb 10, 2017 Research and ... "Personalized Medicine - Scientific and Commercial Aspects" to ... ... Diagnosis is integrated with therapy for selection of treatment as ... detection and prevention of disease in modern medicine. Biochip/microarray technologies ...
(Date:2/8/2017)... YORK , Feb. 8, 2017 About ... individual,s voice to match it against a stored ... such as pitch, cadence, and tone are compared ... require minimal hardware installation, as most PCs already ... for different transactions. Voice recognition biometrics are most ...
(Date:2/8/2017)... Report Highlights ... The global synthetic-biology market reached nearly $3.9 billion in ... a compound annual growth rate (CAGR) of 24.0% through 2021. ... for synthetic biology. - Analyses of global market trends, with ... annual growth rates (CAGRs) through 2021. - Coverage of core ...
Breaking Biology News(10 mins):